These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 22938159)

  • 21. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience.
    Mujtaba MA; Fridell JA; Higgins N; Sharfuddin AA; Yaqub MS; Kandula P; Chen J; Mishler DP; Lobashevsky A; Book B; Powelson J; Taber TE
    Clin Transplant; 2012; 26(5):E492-9. PubMed ID: 22938159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
    Everly MJ
    Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY; Kaneku H; Farmer DG
    Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
    Everly MJ
    Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2012 annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H
    Clin Transpl; 2012; ():207-17. PubMed ID: 23721024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Alloantibodies in Solid Organ Transplantation.
    Everly MJ
    Clin Transpl; 2014; ():125-9. PubMed ID: 26281136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of HLA antibody monitoring after kidney transplantation.
    Morath C; Opelz G; Zeier M; Süsal C
    J Immunol Res; 2014; 2014():845040. PubMed ID: 25374891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the role of HLA antibodies in hematopoietic stem cell transplantation.
    Brand A; Doxiadis IN; Roelen DL
    Tissue Antigens; 2013 Jan; 81(1):1-11. PubMed ID: 23216286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
    McCaughan JA; Tinckam KJ
    Transpl Int; 2018 Oct; 31(10):1059-1070. PubMed ID: 30062683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of specific anty-HLA alloantibodies before and after renal transplantation. Programs for highly sensitized recipients].
    Zielińska H; Zieliński M; Moszkowska G; Debska-Slizień A; Jankowska MM; Rutkowski B; Trzonkowski P
    Postepy Hig Med Dosw (Online); 2009 Sep; 63():435-48. PubMed ID: 19837986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney transplantation in the hyperimmunized patient.
    Gloor J
    Contrib Nephrol; 2005; 146():11-21. PubMed ID: 15567916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.
    Wiebe C; Nickerson P
    Curr Opin Organ Transplant; 2013 Aug; 18(4):470-7. PubMed ID: 23695596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using HLA antibody detection, monitoring, and treatment to improve long-term allograft survival.
    Everly MJ
    Clin Transpl; 2010; ():317-22. PubMed ID: 21696049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor-specific antibodies in kidney transplantation: the University of Wisconsin experience.
    Garg N; Parajuli S; Mandelbrot DA; Djamali A
    Curr Opin Organ Transplant; 2020 Dec; 25(6):543-548. PubMed ID: 33044350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor HLA-specific Abs: to BMT or not to BMT?
    Leffell MS; Jones RJ; Gladstone DE
    Bone Marrow Transplant; 2015 Jun; 50(6):751-8. PubMed ID: 25706884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloimmunity in pancreas transplantation.
    Aziz F; Mandelbrot D; Parajuli S; Al-Qaoud T; Redfield R; Kaufman D; Odorico JS
    Curr Opin Organ Transplant; 2020 Aug; 25(4):322-328. PubMed ID: 32692039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The generation and maintenance of serum alloantibody.
    Clatworthy MR; Espeli M; Torpey N; Smith KG
    Curr Opin Immunol; 2010 Oct; 22(5):669-81. PubMed ID: 20932734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.